Content about Guggenheim Partners

August 30, 2012

Club retailer Costco Wholesale posted sales of $7.4 billion for the month of August, reporting an 8% sales increase over August 2011 and an increase in comps that beat analysts' expectations.

ISSAQUAH, Wash. — Club retailer Costco Wholesale posted sales of $7.4 billion for the month of August, reporting an 8% sales increase over August 2011 and an increase in comps that beat analysts' expectations.

Same-store sales for the chain during the four-week period that ended Sunday increased by 6% over the same period a year ago, reaching the high end of Citi's forecast of 4% to 6% and exceeding Guggenheim Partners' 4% forecast.

July 5, 2012

Rite Aid's same-store sales decreased in June, compared with June 2011, due largely to a decrease in pharmacy comps, the retail pharmacy chain said Thursday.

CAMP HILL, Pa. — Rite Aid's same-store sales decreased in June, compared with June 2011, due largely to a decrease in pharmacy comps, the retail pharmacy chain said Thursday.

The 1% decrease in overall comps included a 1.6% decrease in pharmacy same-store sales — including a negative effect of 672 basis points from new generic introductions — and a 0.3% increase in front-end same-store sales. Prescription count at comparable stores increased 2.9%.

March 15, 2012

A takeover by Walgreens is "highly unlikely," but Rite Aid shares could stay past the $2 mark due to the company's fundamentals, an analyst said Thursday.

NEW YORK — A takeover by Walgreens is "highly unlikely," but Rite Aid shares could stay past the $2 mark due to the company's fundamentals, an analyst said Thursday.

September 29, 2011

Rite Aid same-store sales increased by 1.3% in September, compared with September 2010, the company said Thursday.

CAMP HILL, Pa. — Rite Aid same-store sales increased by 1.3% in September, compared with September 2010, the company said Thursday.

During the four-week period that ended Saturday, front-end same-store sales were down 0.5%, though pharmacy same-store sales increased 2.1%, including a 143-basis point negative effect from new generic introductions.